Thyroid hormone receptor antagonists for cardiac and metabolic disorders II
2 Assignments
0 Petitions
Accused Products
Abstract
This invention relates to novel compounds which are thyroid receptor ligands, preferably antagonists, and to methods for using such compounds in the treatment of cardiac and metabolic disorders, such as cardiac arrhythmias, thyrotoxicosis, subclinical hyperthyrodism and liver diseases.
-
Citations
11 Claims
- 1. A compound according to formula I:
-
10. The compound of Formula I, wherein said prodrug ester form is pivaloyloxymethyl.
-
11. The compound of Formula I, wherein said prodrug ester form is dioxolenylmethyl.
Specification